A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Essen Biotech
Washington University School of Medicine
Curacell Holding AB
Hadassah Medical Organization
Medicenna Therapeutics, Inc.
Indapta Therapeutics, INC.
Essen Biotech
Essen Biotech
Essen Biotech
Essen Biotech
Essen Biotech
Tongji Hospital
Erasmus Medical Center
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University